Inhibiting ADAR1-Mediated Excessive Epigenetic A-to-I RNA Editing Improves the Immune Microenvironment and Increases Sensitivity to Immunotherapy in Lung Adenocarcinoma. [PDF]
Wang S +10 more
europepmc +1 more source
Expanding the proteome: A-to-I RNA editing provides an adaptive advantage. [PDF]
Lewis ZA.
europepmc +1 more source
Bisphenol A (BPA), a common chemical in plastics, exerts dual effects on bladder cancer cells: low doses promote growth and migration, while high doses suppress growth and migration. Multi‐omics and bioinformatics reveal BPA acts via MAPK and inflammatory pathways.
Shaomin Niu +10 more
wiley +1 more source
Biological and prognostic relevance of A-to-I RNA editing across consensus molecular subtypes of colon cancer. [PDF]
Monaco D +13 more
europepmc +1 more source
Transcriptome analysis identification of A-to-I RNA editing in granulosa cells associated with PCOS. [PDF]
Kong FS +10 more
europepmc +1 more source
14‐day casting‐induced immobilization reduced gastrocnemius muscle mass and increased non‐heme iron and ferritin heavy chain levels. Despite iron accumulation, transferrin receptor 1 and iron regulatory protein 2 were paradoxically upregulated. Lipid peroxidation was elevated without compensatory antioxidant responses.
Haruka Yokogawa +2 more
wiley +1 more source
Editome profiling and cross-cohort validation reveal A-to-I RNA editing dysregulation in the hippocampus and prefrontal cortex of sepsis patients. [PDF]
Shen J +6 more
europepmc +1 more source
The occurrence, characteristics, and adaptation of A-to-I RNA editing in bacteria: A review. [PDF]
Liao W, Nie W, Ahmad I, Chen G, Zhu B.
europepmc +1 more source
MiR‐513a promotes human erythroid differentiation by modulating c‐Jun
During early human erythropoiesis, miR‐513a promoted erythroid differentiation in primary human CD34+ hematopoietic stem‐progenitor cells and human TF‐1 erythroleukemic cells by indirectly decreasing c‐Jun and phospho‐c‐Jun expression, which are associated with increased GATA1 expression.
MinJung Kim +11 more
wiley +1 more source
Identification of ADAR1i-124: The first effective A-to-I RNA editing inhibitor with promising cancer therapeutic potential. [PDF]
Minakuchi M +8 more
europepmc +1 more source

